European Companies Search Engine
Entrada Therapeutics Inc., Boston, United States
Watch
If you put a company on your watch list, we'll notify you on your email address when there are new publications regarding this company.
Dossier
The dossier is a printable PDF file, summarizing information and publications for this company. The creation of dossiers is included in your subscription. After the creation of the dossier is completed, it will be sent to your email address .
Add to dossier (if available):
Name
Entrada Therapeutics Inc.
Identification
Stockp
TRDA
Address
Corporate purpose
2834
Pharmaceutical Preparations
Entrada Therapeutics, Inc., a biotechnology company, develops endosomal escape vehicle (EEV) therapeutics for the treatment of multiple neuromuscular diseases. Its endosomal escape vehicle platform develops a portfolio of oligonucleotide, antibody, and enzyme-based programs. The company's lead product candidate is ENTR-601-44, which is in preclinical trail for the treatment of Duchenne muscular dystrophy and myotonic dystrophy type 1. It also engages in the development of EEV-PMO-CAG for the treatment of myotonic dystrophy type 1. The company was formerly known as CycloPorters, Inc … Show more
History
Network
Loading network
Annual report
Publications
13 Jul 2023
There are no publications matching your search.
The data on this page is generated by a fully automated algorithm. It may have errors, and is provided on an "as is" basis with no guarantees of completeness, accuracy, usefulness or timeliness.
The visualizations for "Entrada Therapeutics Inc., Boston, United States"
are provided by
North Data
and may be reused under the terms of the
Creative Commons CC-BY license.
